Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus dexamethasone added to bupivacaine TAP block after laparoscopic cholecystectomy
IRCT20161126031095N4Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine, dexamethasone and dexmedetomidine in postprocedural pain (CPSP) (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Pain intensity, Nausea and 1 more. Started Jun 2023; status: completed.
02
Drugs
bupivacainedexamethasonedexmedetomidine
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on IRCT20161126031095N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161126031095N4.